Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Delphine Mollon"'
Autor:
Dominique Berton, Anne Floquet, Willy Lescaut, Gabriel Baron, Marie-Christine Kaminsky, Philippe Toussaint, Rémy Largillier, Aude-Marie Savoye, Jérôme Alexandre, Catherine Delbaldo, Emmanuelle Malaurie, Hugues Barletta, Claire Bosacki, Claire Garnier-Tixidre, Philippe Follana, Hortense Laharie-Mineur, Charles Briac Levache, Bruno Valenza, Agnès Dechartres, Delphine Mollon-Grange, Frédéric Selle
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Bevacizumab-containing therapy is considered a standard-of-care front-line option for stage IIIB–IV ovarian cancer based on results of randomized phase 3 trials. The multicenter non-interventional ENCOURAGE prospective cohort study as
Externí odkaz:
https://doaj.org/article/759e5d59f76b40d9ba13a0b2c9ebd372
Autor:
Claire Falandry, Fanny Pommeret, Laurence Gladieff, Fabien Tinquaut, Domenica Lorusso, Marie-Ange Mouret-Reynier, Véronique D'Hondt, Delphine Mollon-Grange, Anne Floquet, Sophie Abadie-Lacourtoisie, Pierre-Emmanuel Brachet, Laetitia Stefani, Frédérique Rousseau, Jean-Sébastien Frenel, Francesco Del Piano, Marja Komulainen, Thomas Warkus, Olivier Trédan, Eric Pujade-Lauraine, Gilles Freyer
Publikováno v:
The Lancet Healthy Longevity. 3:e176-e185
Older patients with ovarian cancer represent a heterogeneous population. The French National Group of Investigators for the Study of Ovarian and Breast Cancer developed the geriatric vulnerability score (GVS) to identify geriatric parameters predicti
Autor:
Karim Chikh, Charlotte Cuerq, Marie Valero, Olivier Colomban, Aude-Marie Savoye, Dominique Berton, Laëtitia Stefani, Michel Fabbro, Cyriac Blonz, Olivier Tredan, Margot Noblecourt, Oana Cojocarasu, Delphine Mollon-Grange, Fabrice Barlesi, Eric Pujade-Lauraine, Gilles Freyer, Benoit You, Hubert Vidal, Claire Falandry
Publikováno v:
Ovarian cancer.
Autor:
Olivier Colomban, Emmanuelle Bourbouloux, Marie-Ange Mouret-Renier, Domenica Lorusso, Cyriac Blonz, Aude Marie Savoye, Gilles Freyer, Margot Noblecourt, Michel Gatineau, Laëtitia Stefani, Laurence Gladieff, Florence Joly, Laurence Venat-Bouvet, Delphine Mollon-Grange, Ulla Peen, Lucia Borgato, Eric Pujade-Lauraine, Benoit You, Claire Falandry
Publikováno v:
Ovarian cancer.
Autor:
François-Clément Bidard, Anne-Claire Hardy-Bessard, Florence Dalenc, Thomas Bachelot, Jean-Yves Pierga, Thibault de la Motte Rouge, Renaud Sabatier, Coraline Dubot, Jean-Sébastien Frenel, Jean Marc Ferrero, Sylvain Ladoire, Christelle Levy, Marie-Ange Mouret-Reynier, Alain Lortholary, Julien Grenier, Camille Chakiba, Laetitia Stefani, Jérôme Edouard Plaza, Florian Clatot, Luis Teixeira, Véronique D'Hondt, Hélène Vegas, Olfa Derbel, Claire Garnier-Tixidre, Jean-Luc Canon, Barbara Pistilli, Fabrice André, Laurent Arnould, Anne Pradines, Ivan Bièche, Céline Callens, Jérôme Lemonnier, Frédérique Berger, Suzette Delaloge, Francois-Clement BIDARD, Barbara PISTILLI, Florence DALENC, Thomas BACHELOT, Thibault DE LA MOTTE ROUGE, Renaud SABATIER, Coraline DUBOT, Jean-Sébastien FRENEL, Jean-Marc FERRERO, Sylvain LADOIRE, Christelle LEVY, Marie-Ange MOURET-REYNIER, Anne-Claire HARDY-BESSARD, Alain LORTHOLARY, Julien GRENIER, Camille CHAKIBA, Laetitia STEFANI, Patrick SOULIE, Jean-Philippe JACQUIN, Jérôme Edouard PLAZA, Florian CLATOT, Luis TEIXEIRA, Véronique D'HONDT, Hélène VEGAS, Olfa DERBEL, Claire GARNIER TIXIDRE, Catherine DELBALDO, Lionel MOREAU, Caroline CHENEAU, Jean-François PAITEL, Chantal BERNARD-MARTY, Dominique SPAETH, Dominique GENET, Isabelle MOULLET, Nathalie BONICHON-LAMICHHANE, Laura DEIANA, Charlotte GREILSAMER, Laurence VENAT-BOUVET, Valérie DELECROIX, Adrien MELIS, Hubert ORFEUVRE, Suzanne NGUYEN, Eric LEGOUFFE, Alain ZANNETTI, Romuald LE SCODAN, Nadine DOHOLLOU, Philippe DALIVOUST, Olivier ARSENE, Nathalie MARQUES, Thierry PETIT, Delphine MOLLON, Jérôme DAUBA, Nathalie BONNIN, François MORVAN, Miriam GARDNER, Adina MARTI, Charles-Briac LEVACHE, Emma LACHAIER, Mihaela ACHILLE, Christophe VALMAR, Ryan BOUAITA, Jacques MEDIONI, Cyril FOA, Francesco DEL PIANO, Michel GOZY, Anne ESCANDE, Nicolas LEDUC, Brigitte LUCAS, Dominique MILLE, Hanifa AMMARGUELLAT, Abeer NAJEM, Fanny TROUBOUL, Philippe BARTHELEMY, Hervé DESCLOS, Didier MAYEUR, Fabrice LORCHEL, François GUINET, Anne-Pascale LAURENTY, Axelle BOUDRANT, Olivier GISSEROT, Corinne ALLEAUME, Aimery DE GRAMONT
Publikováno v:
Lancet Oncology
Lancet Oncology, 2022, 23 (11), pp.1367-1377. ⟨10.1016/S1470-2045(22)00555-1⟩
Lancet Oncology, 2022, 23 (11), pp.1367-1377. ⟨10.1016/S1470-2045(22)00555-1⟩
In advanced oestrogen receptor-positive, HER2-negative breast cancer, acquired resistance to aromatase inhibitors frequently stems from ESR1-mutated subclones, which might be sensitive to fulvestrant. The PADA-1 trial aimed to show the efficacy of an
Autor:
Elisabeth Carola, Séverine Guiu, Olivier Tredan, Florence Dalenc, Geraldine Martineau, Laurence Venat Bouvet, Hervé Bonnefoi, Delphine Mollon, Christelle Levy, Marie Ange Mouret Reynier, Florence Lerebours, Mahasti Saghatchian, Marina Pulido, Anthony Gonçalves, Gaëtan MacGrogan
Publikováno v:
Cancer Research. 81:PS12-05
Background: Triple negative breast cancer (TNBC) is an heterogeneous disease and encompasses at least 4 subtypes. One of these expresses the androgen receptor (AR). Several prospective trials demonstrated antitumour efficacy with anti-androgen treatm
Autor:
E. Malaurie, Claire Bosacki, Aude-Marie Savoye, Claire Garnier-Tixidre, Philippe Toussaint, Agnès Dechartres, Rémy Largillier, Gabriel Baron, Marie-Christine Kaminsky, Dominique Berton, Bruno Valenza, Willy Lescaut, Hortense Laharie-Mineur, Jérôme Alexandre, Anne Floquet, Frédéric Selle, Charles Briac Levache, Hugues Barletta, Philippe Follana, Delphine Mollon-Grange, Catherine Delbaldo
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.711813⟩
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.711813⟩
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Bevacizumab-containing therapy is considered a standard-of-care front-line option for stage IIIB–IV ovarian cancer based on results of randomized phase 3 trials. The multicenter non-interventional ENCOURAGE prospective cohort study as
Autor:
Frederique Penault-Llorca, Florence Dalenc, Sylvie Chabaud, Paul Cottu, Djelila Allouache, David Cameron, Jean-Philippe Jacquin, Julien Grenier, Laurence Venat Bouvet, Apurna Jegannathen, Mario Campone, Francesco Del Piano, Marc Debled, Anne-Claire Hardy-Bessard, Sylvie Giacchetti, Philippe Barthelemy, Laure Kaluzinski, Audrey Mailliez, Marie-Ange Mouret-Reynier, Eric Legouffe, Anne Cayre, Mathilde Martinez, Catherine Delbaldo, Delphine Mollon-Grange, E. Jane Macaskill, Matthew Sephton, Laëtitia Stefani, Blaha Belgadi, Matthew Winter, Hubert Orfeuvre, Magali Lacroix-Triki, Herve Bonnefoi, Judith Bliss, Jean-Luc Canon, Jerome Lemonnier, Fabrice Andre, Thomas Bachelot
Publikováno v:
Cancer Research. 82:PD9-08
Background: The double blind randomized UNIRAD trial (NCT01805271) showed no evidence that adding Everolimus (EVE) to adjuvant endocrine therapy (EHT) for high-risk early breast cancer (BC) improved 3-year disease-free survival (iDFS) compared with E
Autor:
Sophie Abadie-Lacourtoisie, Claude El Kouri, Alain Zannetti, Catherine Delbaldo, Isabelle Ray-Coquard, J. Cretin, Elsa Kalbacher, Anne Mercier-Blas, Anne-Claire Hardy-Bessard, Dominique Berton-Rigaud, Emmanuel Blot, Anne Lesoin, Florence Joly, Delphine Mollon, Benoit You, Michel Fabbro, Clémence Romeo, Gilles Freyer, Oana Cojocarasu, Magali Provansal
Publikováno v:
Gynecologic oncology. 152(1)
Background Carboplatin and pegylated liposomal doxorubicin combination is a standard regimen in platinum-sensitive recurrent ovarian cancer patients. The pegylated liposomal doxorubicin shortage from 2011 to 2013 urged assessment of the efficacy and
Autor:
H. Orfeuvre, Dominique Berton-Rigaud, I.L. Ray-Coquard, M. Baron, Delphine Mollon, A.M. Savoye, Rémy Largillier, P.-E. Cailleux, A. Marti, Patricia Pautier, J.-B. Paoli, J.-L. Mouysset, Eric Pujade-Lauraine, W. Lescaut, Anne Floquet, H. Barletta, Frédéric Selle, M. C. Kaminsky, C. Cornea
Publikováno v:
Annals of Oncology. 27:vi308